Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies
Sponsor: Mirati Therapeutics Inc.
Summary
This is an open-label, solid tumor, continuation, rollover trial which enrolls participants from ongoing BMS parent studies that evaluated adagrasib (MRTX849, BMS-986503) either as monotherapy or in combination with other cancer therapies in patients with non-small cell lung cancer (NSCLC), colorectal cancer (CRC) and other advanced solid tumors.
Official title: Solid Tumor Study for Long Term Treatment of Cancer Patients Who Have Participated in BMS Parent Studies Investigating Adagrasib (BMS-986503)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
170
Start Date
2026-05-16
Completion Date
2028-02-16
Last Updated
2026-04-08
Healthy Volunteers
No
Conditions
Interventions
Adagrasib
Specified dose on specified days
Pembrolizumab
Specified dose on specified days
Cetuximab
Specified dose on specified days
Pemetrexed
Specified dose on specified days
Docetaxel
Specified dose on specified days
Irinotecan
Specified dose on specified days
Leucovorin
Specified dose on specified days
Oxaliplatin
Specified dose on specified days
Fluorouracil
Specified dose on specified days
Locations (30)
Local Institution - 0005
Phoenix, Arizona, United States
Local Institution - 0016
Bellflower, California, United States
Local Institution - 0003
Newark, Delaware, United States
Local Institution - 0001
St. Petersburg, Florida, United States
Local Institution - 0064
Chicago, Illinois, United States
Local Institution - 0017
Rochester, Minnesota, United States
Local Institution - 0073
Saint Paul, Minnesota, United States
Local Institution - 0036
Omaha, Nebraska, United States
Local Institution - 0028
East Syracuse, New York, United States
Local Institution - 0004
Eugene, Oregon, United States
Local Institution - 0023
Germantown, Tennessee, United States
Local Institution - 0002
Grapevine, Texas, United States
Local Institution - 0013
Bellingham, Washington, United States
Local Institution - 0072
Vancouver, British Columbia, Canada
Local Institution - 0012
München, Germany
Local Institution - 0014
Lisbon, Lisbon District, Portugal
Local Institution - 0060
Craiova, Dolj, Romania
Local Institution - 0007
A Coruña, A Coruña [La Coruña], Spain
Local Institution - 0010
Barcelona, Barcelona [Barcelona], Spain
Local Institution - 0006
Badalona, Barcelona, Spain
Local Institution - 0030
Santander, Cantabria, Spain
Local Institution - 0029
Barcelona, Spain
Local Institution - 0025
Barcelona, Spain
Local Institution - 0027
Córdoba, Spain
Local Institution - 0024
Madid, Spain
Local Institution - 0009
Madrid, Spain
Local Institution - 0015
Madrid, Spain
Local Institution - 0018
Málaga, Spain
Local Institution - 0011
Palma de Mallorca, Spain
Local Institution - 0008
Seville, Spain